A new RNA-based blood test can predict preeclampsia risk early in pregnancy even in women without known risk factors.

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $39.11, with a +1.48% movement compared to the previous day. This move lagged the S&P 500's daily gain of 2.03%. At the same time, the ...

Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in ...

Australian and Dutch researchers have uncovered a remarkable evolutionary adaptation in birds that could hold vital clues for ...

Researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine.